These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3820567)

  • 41. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
    Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
    Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ticarcillin/clavulanic acid treatment of gynecological infections.
    Gutschow K; Weissenbacher ER; Wachter I; Schneider A; Adam D; Götz A
    Acta Eur Fertil; 1987; 18(2):123-4. PubMed ID: 3630573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NTP Toxicology and Carcinogenesis Studies of Roxarsone (CAS No. 121-19-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Mar; 345():1-198. PubMed ID: 12724787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chronic toxicity study of latamoxef in beagle dog (author's transl)].
    Muraoka Y; Nara H; Yoshizaki T; Harada Y
    Jpn J Antibiot; 1982 Jan; 35(1):222-39. PubMed ID: 6461778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NTP Toxicology and Carcinogenesis Studies of Technical Grade Sodium Xylenesulfonate (CAS No. 1300-72-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Jun; 464():1-272. PubMed ID: 12579200
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicology and Carcinogenesis Studies of C.I. Acid Red 114 (CAS No. 6459-94-5) in F344/N Rats (Drinking Water Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1991 Dec; 405():1-236. PubMed ID: 12621513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NTP technical report on the toxicity studies of 2-Hydroxy-4-methoxybenzophenone (CAS No. 131-57-7) Adminstered Topically and in Dosed Feed to F344/N Rats and B6C3F1 Mice.
    French JE
    Toxic Rep Ser; 1992 Oct; 21():1-E14. PubMed ID: 12209185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
    Bristol DW
    Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NTP Toxicology and Carcinogenesis Studies of Nitrofurazone (CAS No. 59-87-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1988 Jun; 337():1-183. PubMed ID: 12732899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ticarcillin/clavulanate in the treatment of pelvic infections.
    Lucas MJ; Cox SM; Roark ML; Cunningham FG
    J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 9-week recovery test].
    Ishibashi S; Nishizawa Y; Taniguchi Y; Kikumori M; Nishimori T; Iwakura K; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():237-57. PubMed ID: 9019560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Toxicological studies on a new cephamycin, MT-141, IV. Its acute toxicity in beagle dogs].
    Kurebe M; Yokota M; Kawaoto H; Niizato T; Hayasaka H; Seki M
    Jpn J Antibiot; 1984 Jun; 37(6):1070-99. PubMed ID: 6436546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Five-week subacute intravenous toxicity study of cefodizime sodium in dogs].
    Nakano S; Yada H; Irimura K; Kurokawa K; Hirota T; Morita K
    J Toxicol Sci; 1988 Jun; 13 Suppl 1():43-90. PubMed ID: 3172296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Four-week intravenous toxicity study of montirelin hydrate (NS-3) in dogs followed by 4-week recovery test].
    Harling RJ; Gopinath C; Matthiesen T; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():215-36. PubMed ID: 9019559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Toxicological studies on a new cephamycin, MT-141. V. Its subacute toxicity in beagle dogs].
    Kurebe M; Sasaki H; Yokota M; Watanabe H; Suzuki H; Sakamoto K; Hayasaka H
    Jpn J Antibiot; 1984 Jun; 37(6):1100-36. PubMed ID: 6436547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.